David Beier - Profile and Investment Details

Investor Profile

David Beier is a Venture Capital based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as Dermira, Phenomix, NuPathe, Cydan, TRIA Beauty, SynGen, Vivaldi Biosciences, PTC Therapeutics, Sunesis Pharmaceuticals, Epizyme, Hyperion Therapeutics, Avera Pharmaceutical, Oculis, Altheos, Ascendancy, VIA Pharmaceuticals, UCSF Benioff Children's Hospital Oakland, Xeris Pharmaceuticals, BrainCells, Imara, Aragon Surgical, Oculex Pharmaceuticals, Vice President of the Unites States, Reliant Pharmaceuticals, CymaBay Therapeutics, NextWave Pharmaceuticals, Nevro, NextCure, IDEV Technologies, Accriva Diagnostics, Interleukin Genetics, Epocrates, Aviir, Steinberg Institute, Pharmion, Aciex Therapeutics, Nabsys, California Life Sciences Association (CLSA), Ion Torrent, Civitas Therapeutics, Fabric Genomics (formerly Omicia), Xilio Therapeutics, Vtesse, Radiant Medical, EnteroMedics, Cadence Pharmaceuticals, Conatus Pharmaceuticals, Gossamer Bio, Calypso Medical, VYNE Therapeutics, KBP Biosciences, Merus, Presidio Pharmaceuticals, Gritstone Oncology, NBI Development, PharmAkea Therapeutics, Twist Bioscience, Kezar Life Sciences, Bay City Capital, Iterum Therapeutics, Arcus Biosciences, MAP Pharmaceuticals, . Over time, David Beier has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether David Beier is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Customer Service, Parks, Wellness, Women Founded, Enterprise Software, Infrastructure, Transportation, Public Policy, Life Science, Engineering, Education, Senior Care, Science, Finance, Software, Biotechnology, Business Management, Genomics, Innovation, Consumer Software, Health Diagnostics, Renewable Energy, Medical, Information Technology, B2B, Real Estate, Therapeutics, Pharmaceuticals, Mental Health may find it worthwhile to explore potential connections with David Beier, as their portfolio suggests a familiarity and interest in this area.

Understanding David Beier’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.